Dr. Marcus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Cmsc 800
Baltimore, MD 21287Phone+1 410-614-5055
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Yale-New Haven Medical CenterResidency, Pediatrics, 2004 - 2007
Virginia Commonwealth University School of MedicineClass of 2004
Certifications & Licensure
PA State Medical License 2017 - 2024
DC State Medical License 2011 - 2016
VA State Medical License 2010 - 2012- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 205 citationsFDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid TumorsLeigh Marcus, Lola Fashoyin-Aje, Martha Donoghue, Mengdie Yuan, Lisa Rodriguez
Clinical Cancer Research. 2021-06-03 - 79 citationsFDA Approval Summary: Pembrolizumab for the first-line treatment of patients with MSI-H/dMMR advanced unresectable or metastatic colorectal carcinomaSandra Casak, Leigh Marcus, Lola Fashoyin-Aje, Sirisha Mushti, Joyce Cheng
Clinical Cancer Research. 2021-04-12 - 59 citationsFDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumorsLeigh Marcus, Martha Donoghue, Stephanie Aungst, Claire E. Myers, Whitney S. Helms
Clinical Cancer Research. 2021-02-15
Press Mentions
Professional Claims Bureau, Inc. Joins Meduit to Expand Market Share and Services as One of the Nation’s Largest Healthcare Revenue Cycle Solutions CompaniesFebruary 5th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
